Sponsors

Yellow fever viral protein antibodies

ViroStat has just released a new set of monoclonal antibodies to the NS1 protein of the yellow fever virus. This protein appears early during the infection in the serum of those infected. These antibodies do not cross react with related flaviviruses.

Yellow fever virus, a member of the flaviviruses, is transmitted to humans via infected mosquitos. Infection occurs in tropical areas including Africa and South America. Typical symptoms include chills, fever, nausea and muscle pain, with improvement usually seen in five days. However, fever can return in some and lead to liver damage, as evidenced by yellowing of the skin. Vaccine is available for travellers to endemic areas.

Enzyme-linked immunosorbent assay (ELISA) pairing recommendations can be found on the datasheet which can be downloaded from the website below.

www.virostat-inc.com

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-11 March, 2025

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026